Hypertension drug may benefit diabetics, researchers say

09/26/2008 | Yahoo!

Candesartan, a blood-pressure drug, decreased the incidence of retinopathy in patients with Type 1 diabetes by 18% and lowered progression of the eye disorder by 35%, U.K. researchers reported. The findings add to evidence of the potential of the drug -- sold by AstraZeneca and Takeda Pharmaceutical as Atacand -- to reduce or prevent diabetic retinopathy.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA